Remove Disease Remove Nuclear Medicine Remove PET Scan
article thumbnail

PET Scans Reveal ‘smoldering’ Inflammation in patients with Multiple sclerosis

Imaging Technology

The findings were published in Clinical Nuclear Medicine. Microglia are immune cells in the brain that are thought to have a role in MS disease progression but cannot be seen by a routine MRI. The team developed a technique called F18 PBR 06 PET imaging.

PET Scan 102
article thumbnail

SNMMI: Kuo discusses imaging in Pluvicto patients, new Alzheimer’s disease treatment

AuntMinnie

TORONTO -- AuntMinnie.com spoke with prostate cancer imaging expert Phillip Kuo, MD, PhD, of the City of Hope in Duarte, CA, at the Society of Nuclear Medicine and Molecular Imaging annual meeting about new developments in PET/CT imaging in patients on Lu-177 PSMA-617 therapy. last year for Alzheimer's disease.

Disease 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

New tau PET tracer shows promise in Alzheimer’s disease patients

AuntMinnie

PET imaging using a newly developed radiotracer has identified different patterns of brain tau pathology over time in early-onset versus late-onset Alzheimer’s disease patients, according to a study published February 1 in the Journal of Nuclear Medicine. in 15 patients with negative amyloid PET scans; 1.18 in

Disease 130
article thumbnail

PET reveals ‘smoldering’ brain inflammation in patients treated for MS

AuntMinnie

PET brain scans show persistent brain inflammation in patients with multiple sclerosis (MS), despite being treated with high-efficacy disease-modifying therapies, according to a recent study by researchers in Boston. The researchers performed F-18 PBR06 PET scans on 22 patients with MS and eight healthy controls.

article thumbnail

CMS lifts limit on amyloid PET coverage

AuntMinnie

Centers for Medicare and Medicaid Services (CMS) announced on October 13 that it has lifted its coverage limit of one beta-amyloid PET scan per lifetime for patients with Alzheimer’s disease. Medicare coverage decisions for amyloid PET scans will now be made by local Medicare Administrative Contractors (MACs).

article thumbnail

PET reveals patient responses to new Alzheimer’s disease drug

AuntMinnie

Patients with less tau pathology on PET scans may respond better to treatment with the new Alzheimer’s disease drug donanemab, according to an October 25 news report in the journal Practical Neurology. Donanemab is a monoclonal antibody designed to bind to beta-amyloid protein that already has formed into plaque deposits.

Disease 119
article thumbnail

CMS proposes new coverage for PET imaging agents

AuntMinnie

Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).